Pediatric Leukemia Clinical Trials
Category:Pediatric
Status:Active
Displaying all 13 trials
This partially randomized phase III clinical trial is studying different combinations of risk-adapted chemotherapy regimens and their side effects and comparing how well they work in treating young...
Diagnosis: Pediatric Oncology, Pediatric Leukemia
Phase: 3
Protocol Number: 12-211
This randomized phase III trial is studying how well combination chemotherapy works in treating young patients with newly diagnosed acute lymphoblastic leukemia that is likely to come back or sprea...
Diagnosis: Pediatric Leukemia
Phase: 3
Protocol Number: 13-486
This randomized phase III trial compares how well combination chemotherapy works when given with or without bortezomib in treating patients with newly diagnosed T-cell acute lymphoblastic leukemia ...
Diagnosis: Pediatric Lymphoma, Pediatric Leukemia
Phase: 3
Protocol Number: 15-032
This randomized phase II trial studies how well donor umbilical cord blood transplant with or without ex-vivo expanded cord blood progenitor cells works in treating patients with acute myeloid leuk...
Diagnosis: Pediatric Hematopoietic Stem Cell Transplant (HSCT), Pediatric Leukemia
Phase: 2
Protocol Number: 13-042
A Study of LY3039478 in Combination With Dexamethasone in Participants With T-ALL/T-LBL
The main purpose of this study is to evaluate the safety of the study drug known as LY3039478 in combination with dexamethasone in participants with T-cell acute lymphoblastic leukemia or T-cell ly...
Diagnosis: Pediatric Leukemia
Phase: 1 / 2
Protocol Number: 15-226
This research study involves participants who have acute lymphoblastic or acute myelogenous leukemia that has relapsed or has become resistant (or refractory) to standard therapies. This research s...
Diagnosis: Pediatric Leukemia
Phase: 1
Protocol Number: 13-563
The purpose of this study is to test the safety of giving the patient special cells made from their own blood called "Modified T-cells". The goal is to find a safe dose of modified T-cell...
Diagnosis: Pediatric Leukemia
Phase: 1
Protocol Number: 13-526
Matched Targeted Therapy For High-Risk Leukemias
This research study is seeking to gain new knowledge about Recurrent, Refractory, or High Risk Leukemias in children and young adults. This study is evaluating the use of specialized testing called...
Diagnosis: Pediatric Leukemia
Phase: N/A
Protocol Number: 15-384
Tretinoin and Arsenic Trioxide in Treating Patients With Untreated Acute Promyelocytic Leukemia
This phase III trial studies tretinoin and arsenic trioxide in treating patients with newly diagnosed acute promyelocytic leukemia. Standard treatment for acute promyelocytic leukemia involves high...
Diagnosis: Pediatric Leukemia, Pediatric Oncology
Phase:
Protocol Number: 15-719
This study will examine the appropriate dose and side effects of dasatinib, when it is given with the standard of care chemotherapy for children and adolescents with Acute Myeloid Leukemia (AML).
Diagnosis: Pediatric Leukemia
Phase:
Protocol Number: 15-581
This phase I/II trial studies the side effects and best dose of liposomal cytarabine-daunorubicin CPX-351 (CPX-351) when given with fludarabine phosphate, cytarabine, and filgrastim and to see how ...
Diagnosis: Pediatric Leukemia
Phase:
Protocol Number: 16-717
Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents
Acute lymphoblastic leukemia (ALL) is the most common cancer diagnosed in children. The cancer comes from a cell in the blood called a lymphocyte. Normal lymphocytes are produced in the bone marrow...
Diagnosis: Pediatric Leukemia
Phase:
Protocol Number: 16-001
This clinical trial studies the effects of dexrazoxane hydrochloride on biomarkers associated with cardiomyopathy and heart failure after cancer treatment. Studying samples of blood in the laborato...
Diagnosis: Pediatric Lymphoma, Pediatric Leukemia
Phase:
Protocol Number: 16-725
